Simvastatin may restore penicillin efficacy against resistant bacteria

Swedish researchers identified a mechanism by which simvastatin, a cholesterol-lowering drug, could help penicillin overcome resistance in certain bacteria. The finding is preliminary and based on laboratory research, with clinical implications uncertain. It matters because antibiotic resistance is a growing global health threat, and repurposing existing drugs could offer a new therapeutic avenue.